Home > Products > CD16 & EGFR
> Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Miniantibody)
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Miniantibody) (CAT#: MNAB-036)
Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-CD16 antibody variable domain is linked to another scFv of an anti-EGFR antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-EGFR Bispecific Antibody (Miniantibody) (MNAB-036). Click the button below to contact us or submit your feedback about this product.